SUMMARY The investigation examines the hypothesis that metoclopramide-induced potentiation of gastrointestinal motility is mediated through dopamine receptors. In vitro studies on the longitudinal muscle of the guinea-pig ileum were performed. Metoclopramide, in concentrations comparable with those seen in plasma after therapeutic doses in man, selectively potentiated the cholinergic response. Metoclopramide can block dopamine, and its antiemetic effect probably involves antagonism of dopamine centrally.5 6 The presence of dopamine in gastrointestinal nerve7, raises the possibility tested here that metoclopramide acts peripherally by antagonising dopamine.
Metoclopramide (4-amino-5-chloro-2-methoxy-N-2-diethylaminoethylbenzamide) is used clinically for preventing emesis and increasing gastrointestinal motility'. Its most prominent effect on the gastrointestinal tract of various mammalian species is enhanced motor activity, an action generally attributed to potentiation of intrinsic cholinergic mechanisms of the gastrointestinal tract by metoclopramide. Some have suggested that it acts by promoting the release of acetylcholine from cholinergic nerve terminals,2 while others3 4 have proposed that metoclopramide sensitises muscarinic receptors.
Metoclopramide can block dopamine, and its antiemetic effect probably involves antagonism of dopamine centrally.5 6 The presence of dopamine in gastrointestinal nerve7, raises the possibility tested here that metoclopramide acts peripherally by antagonising dopamine.
Methods
Experiments were carried out on longitudinal muscle strips from guinea-pig ileum. Male guinea-pigs, 300-500g, were killed by a blow on the back of the head, bled out, and the terminal 30-40 cm ileum after discarding the last 20 cm was removed.
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Neither metoclopramide 3-300 MM nor another dopamine-blocker, pimozide, 1 ,uM antagonised the dopamine inhibition of electrically evoked twitches.
Inhibitory a-adrenoceptors are located on the cholinergic nerve supply to the longitudinal muscle of the guinea-pig ileum.12 The possibility that do- Effect ofmetoclopramide in guinea-pig ileum longitudinal muscle: evidence against dopamine-mediation pamine inhibits cholinergic transmission by activating these receptors was tested using phentolamine to block the a-adrenoceptors. Phentolamine (Fig. 6) . The inhibition by bromocriptine was not antagonised by the dopamine receptor antagonists metoclopramide and pimozide, nor, unlike dopamine-induced inhibition, by the a-adrenoceptor antagonist phentolamine (Fig. 7) . Previous studies by other workers in this field have not used the isolated longitudinal muscle preparation of the guinea-pig ileum. As this preparation is thin and allows the drug-receptor interaction to take place rapidly, the in vitro drug response may mimic that which occurs when the drug is carried in the blood stream. The removal of the ileal circular muscle, while unphysiological, enables an accurate assessment of the response of the longitudinal muscle without interference from the circular layer.
Metoclopramide produced enhancement of spontaneous activity, augmentation of electrically evoked cholinergic contraction, and increased tone of the longitudinal muscle. These potentiating actions were selective for cholinergic response, as they were lost Metoclopramide is a dopamine receptor antagonist'4 15 and its anti-emetic action is believed to be mediated by central dopamine receptor mechanisms.5 6 However, although dopamine is present in gastrointestinal tissues,'6-'8 it does not appear that metoclopramide stimulates gastrointestinal motility by antagonising gut dopamine receptors. The presynaptic effect of dopamine, shown by inhibition of electrically evoked cholinergic twitch but not of acetylcholine-induced contraction, was antagonised by the a-adrenoceptor blocker phentolamine, whereas metoclopramide had little effect. Presynaptic inhibitory a-adrenoceptors are known to be present on the cholinergic nerve terminals in this tissue12 and dopamine stimulates o-adrenoceptors.19 -21 The results with pimozide and bromocriptine further confirm that, in guinea-pig ileum, dopamine acts on aadrenoceptors rather than on dopamine receptors, suggesting a lack of dopamine receptors in this tissue. Pimozide, a potent dopamine-receptor antagonist, did not counteract the inhibitory effect of dopamine on cholinergic transmission. Bromocriptine, a dopamine-receptor agonist, inhibited both the response to cholinergic nerve stimulation and to acetylcholine at a post-synaptic site not affected either by the a-adrenoceptor blocker phentolamine or by the dopamine-receptor blockers pimozide and metoclopramide. Thus, in this experimental model, metoclopramide, in concentrations within the range seen in plasma after therapeutic doses in man22, does not seem to act by blocking dopamine receptors but selectively facilitates cholinergic mechanisms by an action which still remains to be elucidated. 
